Table 2.
Groups | Treatment day | Day 9 | Day 17 | Day 20 |
---|---|---|---|---|
Negative control (1A) | 1.33±0.21a | 1.33±0.21a | 1.17±0.19a | 1.17±0.18a |
| ||||
Amprolium (2B) | 3.0±0.26b | 3.17±0.40b | 2.50±0.24b | 2.25±0.23b |
| ||||
Positive control (3C) | 3.17±0.31b | 3.0±0.32b | 2.75±0.24b | 3.0±0.00b |
| ||||
Diclazuril (4D) | 2.67±0.21b | 1.17±0.17a | 1.17±0.19a | 1.0±0.18a |
| ||||
Sulphachloropyrazine (5E) | 2.67±0.21b | 1.33±0.21a | 1.20±0.21a | 1.0±0.20a |
| ||||
Trimethoprim-sulphamethoxazole (6F) | 2.83±0.31b | 2.0±0.37ab | 2.67±0.19b | 2.33±0.18b |
| ||||
SD | 0.838 | 1.043 | 0.860 | 0.844 |
| ||||
p-value | <0.001 | <0.001 | <0.001 | <0.001 |
Values with different superscripts in a column are significantly different at p<0.05.
Fecal score was done according to [22] where a score of 1 indicated normal well-formed pellets through 5, indicating severe diarrhea with/without profuse amount of blood.